Mangrove Partners
- SEC CIK
- 0001535392
- Latest filing
- Aug 14, 2026
LRMR holding history
Larimar Therapeutics, Inc. in every 13F filed by Mangrove Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LRMR overviewAll 13F holders of LRMRFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −442,236−100.0% | Sold out | Holders |
| Q3 2025 | 442,236 | $1.43M | 0.1% | −327,997−42.6% | Reduced | Holders |
| Q2 2025 | 770,233 | $2.23M | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2025 | 770,233 | $1.66M | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2024 | 770,233 | $2.98M | 0.4% | −85,582−10.0% | Reduced | Holders |
| Q3 2024 | 855,815 | $5.61M | 0.5% | 00.0% | Unchanged | Holders |
| Q2 2024 | 855,815 | $6.20M | 0.6% | 00.0% | Unchanged | Holders |
| Q1 2024 | 855,815 | $6.50M | 0.6% | +50,000+6.2% | Added | Holders |
| Q4 2023 | 805,815 | $3.67M | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2023 | 805,815 | $3.18M | 0.3% | 00.0% | Unchanged | Holders |
| Q2 2023 | 805,815 | $2.52M | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2023 | 805,815 | $3.65M | 0.4% | −486,997−37.7% | Reduced | Holders |
| Q4 2022 | 1,292,812 | $5.34M | 0.5% | 00.0% | Unchanged | Holders |
| Q3 2022 | 1,292,812 | $4.14M | 0.4% | +425,000+49.0% | Added | Holders |
| Q2 2022 | 867,812 | $1.70M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 867,812 | $3.52M | 0.3% | +627,859+261.7% | Added | Holders |
| Q4 2021 | 239,953 | $2.59M | 0.2% | +239,953 | New | Holders |